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Tuesday, February 23, 2010 553aamplitude oscillation (frequency: 1 100Hz) and determined elastic and vis-
cous moduli. Results showed that hysteresis was greatly increased in the
KO over the WT (for example at a speed of 100 %/s and an amplitude of
0.3 mm/sarcomere, hysteresis was 15495379pJ/mm2/sarcomere vs. 4015
94pJ/mm2/sarcomere; p<0.05). It can be calculated that this differences in hys-
teresis is analogous to an energy difference in a 24 hour period of 600 BPM of
~16cal, or ~30% of the total energy consumed by the heart. We conclude that
the N2B element greatly reduces energy loss during stretch/shortening cycles
of the beating heart.
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Single Molecule Analysis of PKC Phosphorylation of Titin’s PEVK Domain
Brian Anderson1, Julius Bogolomovas2, Siegfried Labeit2, Henk Granzier1.
1University of Arizona, Tucson, AZ, USA, 2Universita¨tsmedizin Mannheim,
Mannheim, Germany.
Titin’s I-band region contains three spring-like domains that are primarily re-
sponsible for the development of passive tension in cardiac muscle. PKC phos-
phorylation targets one of these I-band domains_the PEVK region, which is
rich in proline (P), glutamate (E), valine (V), and lysine (K). It has been shown
that two serine residues within the PEVK are targeted by PKC phosphorylation,
S26 and S170. We investigate the effects of PKC phosphorylation of these two
residues on the single molecule level using force-extension curves generated by
atomic force microscopy (AFM). We constructed four recombinant proteins:
two PEVK single mutants (S26A and S170A), a PEVK double mutant
(S26AS170A), and a wild-type PEVK segment. All constructs are flanked by
immunoglobulin-like domains, Ig27 and Ig84, and the unfolding of these do-
mains generates a single molecular ‘‘fingerprint’’. The force-extension curve
leading up to the first unfolding peak describes the force-extension relationship
of the PEVK. Preliminary data suggests that mutating either serine residue al-
ters PEVK resistance to extension, which is quantified by the molecule’s per-
sistence length (PL). Wild-type PEVK underwent a large decrease in its PL af-
ter phosphorylation by PKC (by ~50%), and both single mutants have PLs
similar to that of phosphorylated wild-type PEVK. Furthermore, phosphoryla-
tion of both single mutants resulted in a small PL decrease. Phosphorylation de-
creased PL for the S26A mutation by 16% (from 0.555 0.02 to 0.465 0.02
(mean5 SE)), and the serine-170 mutation PL by 11% (from 0.535 0.04 to
0.475 0.03). The double mutant was not affected by PKC (from 0.515 0.04
to 0.515 0.03). We conclude that both serines play a structural role in deter-
mining the relationship between longitudinal force and PEVK extension, and
that this role is modulated through phosphorylation by PKC.
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Passive Stress in Myofibrils from Cardiomyopathic Hamsters
Audree McKenzie, Walter Herzog.
University of Calgary, Calgary, AB, Canada.
Dilated cardiomyopahty (DCM) is a frequent heart disease characterized by
cardiac dilation and contractile dysfunction. The Bio TO-2 hamster is a genetic
animal model of human DCM. The purpose of this research is to study the pro-
gression of DCM by comparing over time the passive mechanical properties of
left ventricular wall myofibrils from TO-2 hamsters to those from F1B control
hamsters. To date, we measured the passive stress-sarcomere length relations
for two myofibrils each from experimental and control animals aged 36 weeks.
Myofibrils were attached at one end to a glass needle controlled by a motor for
stretching, and at the other end to a silicon-nitride nanolever of known stiffness
for force measurements. Sarcomere lengths were measured from the myofibril-
lar striation patterns. Passive stresses in the experimental and control myofibrils
were comparable. More passive me-
chanical experiments will be per-
formed to confirm this result. In a sin-
gle myofibril, titin is thought to be
responsible for essentially all of the
passive stress response to stretch
(Linke et al., 1994; Bartoo et al.,
1997). Titin depletion experiments
and titin molecular weight determina-
tion will therefore also be performed
to detect changes in titin isoform.
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Importance of Titin Based Viscosity in Cardiac Function: an Integrative
Study on PEVK-Actin Interactions
Charles S. Chung1, Methajit Methawasin1, Joseph Popper1,
O. Lynne Nelson2, Michael Gotthardt3, Henk L. Granzier1.
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Pullman, WA, USA, 3Max-Delbruck-Center for Molecular Medicine, Berlin,
Germany.Viscosity has recently been hypothesized as an important regulator of diastolic
relaxation during isovolumic relaxation and early rapid filling. A viscous inter-
action between the proline-glutamic acid-valine-lysine (PEVK) rich region of
titin and the actin filaments has been shown at the protein level, but the phys-
iologic relevance of such an interaction is unclear. A novel PEVK kockout
(KO) mouse was utilized in order to investigate PEVK-actin based viscosity.
KO and wild-type (WT) skinned cardiomyocytes were isolated subjected to
ramp-hold protocols. Our data showed that the viscosity measured via stress re-
laxation was more than 2x greater in the WT vs KO cells and that WT cells
showed a 2x faster relaxation to the steady state force at each of 4 stretch
speeds, a hallmark of viscosity. Also using KO and WT mice, we examined
the presence of viscosity in the intact ventricle. Using both ramp-hold and si-
nusoidal oscillations, we found that, in intact hearts, WT displayed greater vis-
cosity than KO hearts. Ramp-hold analysis on isolated hearts again showed a 2x
faster relaxation in WT (36ms) vs KO (53ms). Sinusoidal analysis provides KO
viscosity nearly 30% lower than WT (Viscous modulus WT=0.97 vs
KO=0.65 [mmHg/uL]). Because physiologic stretch speeds were probed in
stretches on cells and isolated hearts, we analyzed in-vivo echocardiographic
measurements utilizing kinematic models of stiffness and viscosity known as
the Parameterized Diastolic Filling Formalism. As expected with a truncated
titin, stiffness increased in the KO mouse (WT=10,700 vs KO=12,400 mass
normalized stiffness [1/s2]). Importantly, a 30% reduction in viscous properties
(WT=143 vs KO=99 mass normalized viscosity [1/s]). Titin based viscosity
driven by PEVK-actin interactions are present in the ventricle and could play
an important role in diastolic function and dysfunction.
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Diastolic heart failure (DHF) is a common heart disease characterized, e.g., by
delayed relaxation, impaired left ventricular (LV) filling and increased LV stiff-
ness. Titin is an established contributor to LV stiffness, but little is known about
the protein’s contribution to altered diastolic function in DHF. We investigated
LV tissue samples of several animal models of DHF, as well as interventricular
septum samples of aortic stenosis (AS) patients, for titin-isoform composition
by loose-gel electrophoresis and titin-based stiffness by skinned-fiber mechan-
ics. Induction of diastolic dysfunction in a small animal model, the ‘‘two kidney
one clip’’ (2K1C) rat, which develops LV hypertrophy due to chronic afterload
increase, caused no significant changes in the titin-isoform expression pattern,
both 6 weeks and 8 months following surgery (~6% N2BA in both 2K1C and
SHAM-operated LV, the remainder being N2B isoform; N2B contains a stiffer,
N2BA a more compliant titin spring). Similarly, in a volume-overload mouse
model created by aortocaval fistula surgery, cardiac titin isoforms remained un-
altered compared to SHAM-operated animals (18.5% vs. 19.8% mean N2BA).
However, in an old dog model (8-12 years) made hypertensive by bilateral renal
wrapping, the cardiac N2BA proportion was significantly lower (41.654.9%;
mean5SD) than in normal old dog LV (46.254.2%; p<0.020). Mechanical
measurements revealed passive-stiffness modulations consistent with the mag-
nitude of titin-isoform switching. In contrast, in human AS samples, the titin
isoform composition showed 42.054.0% N2BA, significantly higher than in
location-matched normal donor hearts (37.555.0%; p<0.025). We conclude
that diastolic dysfunction is associated with changes in cardiac titin isoform
composition in a large animal model and in humans. The direction and the mag-
nitude of the isoform shift appear to be determined by multiple factors not ex-
cluding, but clearly not restricted to, hemodynamic overload.
2853-Pos
Characterization of a Mutant Rat Model with Altered Titin Isoform Ex-
pression
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Titin isoform expression is related to human cardiac disease. A mutant rat model
with dramatically altered titin isoform expression has been described (Greaser
et al. J Mol. Cell. Cardiol. 44:483, 2009), and the ultrastructural and physiolog-
ical properties of mutant and wild type rats were compared in this study. Electron
micrographs of homozygous mutant ventricles showed normal structure in most
areas, but occasional regions of Z line streaming, myofibrillar disarray, lipofu-
chin granules, and myofibril degeneration were observed as found previously
in human heart failure. Dobutamine administration caused an increased heart
rate in wild type (Wt), heterozygotes (Ht) and homozygote mutants (Hm), but
554a Tuesday, February 23, 2010the dobutamine effects on preload recruitable stroke work and maximal systolic
elastance were significantly blunted in the mutant groups. Maximal exercise ca-
pacity of Wt rats was significantly longer than that of Hm. Electrophoretic my-
osin heavy chain analysis of left ventricle (LV) samples showed no differences
between Wt, Ht, or Hm in the beta myosin heavy chain proportions. Gene ex-
pression patterns in LV were conducted with Affymetrix GeneChip Rat Genome
230 2.0 microarrays using WT and Hm LV at three developmental stages (day 1,
day 20 and day 49). A Student t-test with a p value cut-off of 0.05 and a minimum
1.5-fold change reveals changes in 372 mutation-specific transcripts (188 known
and 96 un-annotated genes). A number of titin associated genes were up-regu-
lated (Myot, T-cap, DARP, FHL1), and this up-regulation was verified by
QPCR. Hierarchical clustering revealed gene expression patterns of Wt and
Hm LV were related to their titin protein gel pattern. Predefined pathways and
functional categories annotated by KEGG, Biocarta, and GO using the DAVID
bioinformatic resource indicated involvement of TGF Beta 2, CTGF-regulated
fibrosis, Trdn-Casq interaction-regulated RyR channel, and cAMP-dependent
pathways. Supported by NIH HL77196.
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Binding of the N-Terminal Fragment C0-C2 of Cardiac MyBP-C to Car-
diac F-Actin
Robert W. Kensler1, Justin F. Shaffer2, Samantha P. Harris2.
1University of Puerto Rico Medical School, San Juan, PR, USA, 2University
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We have previously reported (Shaffer et al. 2009. J. Biol. Chem.284:12318-27) that
the N-terminal fragment C0-C2 of myosin binding protein-C (MyBP-C) can bundle
actin, providing evidence for interaction of MyBP-C and actin. Neutron scattering
studies (Whitten et al. 2008. PNAS 105:18360-5) also demonstrated the formation
of ordered complexes of C0-C2 with actin, but these experiments were conducted
under conditions that stabilized G-actin at reduced ionic strength and pH 8.0. To test
whether C0-C2 also decorates F-actin at physiological ionic strength and pH, we
incubated C0-C2 (5 - 30 uM, in a buffer containing in mM: 180 KCl, 1 MgCl2, 1
EDTA, 1 DTT, 20 imidazole, at pH 7.4) with F-actin (5 uM) for 30 min and exam-
ined negatively-stained samples of the solution by electron microscopy (EM). Anal-
ysis of EM images revealed that C0-C2 bound to F-actin to form long helically-or-
dered complexes with a mean diameter of 16 nm. Fourier transforms indicated that
C0-C2 binds with the helical periodicity of actin with strong 1st and 6th layer lines.
The results provide evidence that the N-terminus of MyBP-C binds regularly to F-
actin. Supported by NIH 5SC1HL096017 (RWK) and NIH HL080367 (SPH).
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Incorporation of the A31P Cardiac Myosin Binding Protein C Missense
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Kristina L. Bezold, Elaine Hoye, Justin Shaffer, Aldrin Gomes,
Mark Kittleson, Samantha Harris.
University of California, Davis, Davis, CA, USA.
Mutations in cardiac myosin binding protein C (cMyBP-C) are a frequent cause of
hypertrophic cardiomyopathy (HCM), a major cause of sudden cardiac death and
heart failure. Mutations include single amino acid substitutions and premature
stop codons, but it is unclear whether dominant negative effects of mutant pro-
teins, depletion of wild-type protein due to an affected allele (haploinsufficiency),
or aberrant protein processing/degradation leads to disease. To distinguish among
these possibilities, we investigated the sarcomeric localization and functional ef-
fects of a spontaneous cMyBP-C missense mutation in Maine Coon cats, a natu-
rally occurring feline model of HCM. Immunofluorescent localization using an
antibody specific for the A31P mutation showed that A31P cMyBP-C was incor-
porated into the sarcomeres of cats heterozygous and homozygous for the A31P
mutation with similar distribution patterns as wild-type cMyBP-C. However,
dominant negative effects due to incorporation of the mutant protein were not ev-
ident because myofilament Ca2þ sensitivity of tension and rate of tension devel-
opment were not different in permeabilized myocytes from wild-type versus
A31P cats. Actin binding and in vitro motility experiments also showed no differ-
ence between wild-type and A31P recombinant feline C0C2 proteins. By contrast,
cytosolic proteasomes from a homozygous cat showed elevated b-5 (chymotryp-
sin-like) proteolitic activity compared to wild-type or heterozygous cats. Addi-
tional experiments are necessary to determine whether aberrant protein degrada-
tion of A31P cMyBP-C contributes to disease. Supported by NIH HL080367.
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Expressing a Truncated Cardiac Myosin Binding Protein-C
Peter J. Griffiths1, Henrik Isackson2, Charles S. Redwood2, Hugh Watkins2,
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Oxford, United Kingdom, 2Department of Cardiovascular Medicine, Oxford
University, Oxford, United Kingdom.We have investigated contractile parameters of ventricular myocardium in
samples from a patient diagnosed with hypertrophic cardiomyopathy (HCM)
caused by a truncation mutation in MYBPC3, the gene encoding cardiac myosin
binding protein C (cMyBP-C). The mutation truncates the protein in the C7 do-
main resulting in the loss of 408 residues. Our earlier work has shown that the
truncated protein is not stably expressed and the disease is likely to be mediated
by cMyBP-C haploinsufficiency.
We measured Ca2þ-sensitivity, isometric force generation, and myosin ATPase
activity in tissue flash frozen in liquid nitrogen and subsequently stored in dry
ice at 80C before chemical demembranation. ATPase activity within the
myocardium was measured simultaneously with force, using a fluorimetric
technique and a linked-enzyme assay. Healthy human cardiac ventricular tissue
served as control.
The mutant tissue exhibited an increased Ca2þ-sensitivity (pCa50 in control:
5.9850.02 (n = 12); mutant: 6.5250.07 (n=6), p<0.001) whereas the maxi-
mum isometric tension was reduced in mutant compared to control (control:
18.553.0 kN.m2 (n = 26); mutant 8.650.8 kN.m2 (n=7), p<0.05). There
was no difference in the ATPase activity in maximally Ca2þ-activated tissue
between the two groups (control, 131520mM.s1 (n=26); mutant,
12759mM.s1 (n=7), p=0.87). The dependence of ATPase activity on force
was linear, with a slope (tension cost) of 7.3250.97mM.m2.kN1.s1 (mutant,
n=6) and 3.4650.87 mM. m2.kN1.s1 (control, n=10), p = 0.01. The increased
tension cost of the mutant sarcomeres may cause energetic compromise, which
has been suggested to play an important role in the development of the HCM
phenotype. Increased Ca2þsensitivity has been reported in other investigations
on HCM myocardium, and may be a direct effect of cMyBP-C haploinsuffi-
ciency or reflect compensatory changes.
Work supported by the British Heart Foundation.
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In skinned myocardium, cAMP-dependent protein kinase (PKA)-catalyzed
phosphorylation of cardiac myosin binding protein-C (cMyBP-C) and troponin
I (cTnI) leads to a decrease in myofilament Ca2þ-sensitivity and an acceleration
in the kinetics of cross-bridge cycling. To examine the relative roles of cTnI
and cMyBP-C phosphorylation in altering contractile function, we determined
the Ca2þ-sensitivity of force (pCa50) and the rate of force redevelopment (ktr)
in untreated and PKA-treated murine myocardium expressing: (1) phosphory-
latable cTnI and cMyBP-C (WT), (2) non-phosphorylatable cTnI with
serines23/24/43/45 and threonine144 residues mutated to alanines (cTnIala5), (3)
phosphorylatable cTnI on a cMyBP-C null background (cMyBP-C-/-), and
(4) non-phosphorylatable cTnI on a cMyBP-C null background (cTnIala5/
cMyBP-C-/-). A novel aspect of this study was the use of 2,3-Butandione Mon-
oxime (BDM) treatments to reduce the basal levels of myosin regulatory light
chain (RLC) phosphorylation to near zero in order to more accurately define the
functional consequences of removing cMyBP-C and/or cTnI phoshorylation in
transgenic myocardium. Our results showed that in the absence of RLC phos-
phorylation, PKA-treatment decreased pCa50 in WT, cTnIala5, and cMyBP-C
-/-
myocardium by 0.13, 0.08 and 0.09 pCa units, respectively, but had no effect in
cTnIala5/cMyBP-C
-/- myocardium. In WT and cTnIala5 myocardium, PKA treat-
ment increased ktr at submaximal levels of activation; however, treatment did
not have an effect on ktr in cMyBP-C
-/- and cTnIala5/cMyBP-C
-/- myocardium.
Together, these results indicate that the attenuation of the myofilament force
response following PKA treatment is due to phosphorylation of both cTnI
and cMyBP-C and that the reduced Ca2þ-sensitivity of force mediated by phos-
phorylation of cMyBP-C is most likely due to an increased rate constant of
cross-bridge detachment that also contributes to an acceleration of cross-bridge
cycling kinetics.
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Endothelin as a Regulator of Phosphorylation of cMyBP-C
Saul Winegrad.
University of Pennsylvania, Philadelphia, PA, USA.
The effect of endothelin, a powerful vasoconstrictor and enhancer of cardiac
contractility, and hypoxia on the degree of phosphorylation of cardiac myosin
binding protein C (cMyBP-C) has been studied in cardiac trabeculae isolated
from rat hearts. Endothelin in concentrations that increase contractility increases
phosphorylation in a dose-dependent fashion. Increase in sarcomere length
itself increases phosphorylation and enhances the effect of endothelin on phos-
phorylation. Hypoxia decreases phosphorylation in a duration-dependent
